RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Regulatory Agency Hub

Health Canada Updates

The latest guidances, approvals, and safety alerts from Health Canada, curated by automated regulatory intelligence.

EVENT
Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination
Health Canada • Published: Nov 16, 2026

Reviews and may reshape Canada’s federal approach to obtaining pandemic science advice and coordinating pandemic research, with implications for how evidence…

infectious_disease
View update →
EVENT
Advisory Committee: National Pharmacare Committee of Experts
Health Canada • Published: Nov 16, 2026

National Pharmacare Committee of Experts—Health Canada advisory body—sets up expert governance intended to inform or support the development of Canada’s…

immunology
infectious_disease
+16
View update →
EVENT
Advisory Committee: Ministerial Advisory Council on Mental Health
Health Canada • Published: Nov 16, 2026

Establishes and describes Health Canada’s Ministerial Advisory Council on Mental Health as an advisory body to support ministerial decision-making in the…

psychiatry
View update →
EVENT
Advisory Committee: Expert Task Force on Substance Use
Health Canada • Published: Nov 16, 2026

Constitutes or highlights Health Canada’s Expert Task Force on Substance Use within the broader advisory body framework, indicating ongoing policy/scientific…

View update →
EVENT
Advisory Committee: Expert Panel on MAID and Mental Illness
Health Canada • Published: Nov 16, 2026

Expert Panel materials on MAID and mental illness indicate Health Canada is examining how psychiatric/mental health conditions intersect with eligibility…

psychiatry
clinical
+4
View update →
EVENT
Advisory Committee: Expert Advisory Group on Safer Supply
Health Canada • Published: Nov 16, 2026

Expert Advisory Group on Safer Supply establishes an advisory mechanism within Health Canada to support approaches aimed at improving the safety of the…

View update →
EVENT
Advisory Committee: Canadian Pain Task Force
Health Canada • Published: Nov 16, 2026

Advises on priorities and evidence-gathering activities related to pain, informing Health Canada’s engagement and potential downstream updates to policies or…

neurology
psychiatry
View update →
EVENT
Advisory Committee: Appropriate Use Advisory Committee
Health Canada • Published: Nov 16, 2026

Establishes an advisory committee structure within Health Canada for considering the appropriate use of health products and/or evidence-based recommendations.

View update →
EVENT
Advisory Committee: Advisory Council on the Implementation of National Pharmacare
Health Canada • Published: Nov 16, 2026

Advises on how to implement National Pharmacare in Canada through guidance from an advisory council focused on policy rollout considerations rather than…

manufacturing
quality
+3
View update →
EVENT
Advisory Committee: Scientific Advisory Board on Vaping Products
Health Canada • Published: Nov 16, 2026

Constitutes Health Canada’s Scientific Advisory Board on Vaping Products, indicating a structured expert advisory mechanism to inform vaping product-related…

respiratory
safety
View update →
EVENT
Advisory Committee: Youth Leadership Team (Substance Use)
Health Canada • Published: Nov 16, 2026

Establishes and convenes a Health Canada youth-focused advisory committee framework on substance use to inform ongoing policy and program considerations.

psychiatry
pediatrics
View update →
EVENT
Advisory Committee: Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases
Health Canada • Published: Nov 16, 2026

Establishes and supports an Implementation Advisory Group (IAG) to coordinate Health Canada’s implementation of the National Strategy for Drugs for Rare…

rare_diseases
clinical
+4
View update →
EVENT
Advisory Committee: Scientific Advisory Committee on Mental Health Disorders
Health Canada • Published: Nov 16, 2026

Scientific Advisory Committee on Mental Health Disorders event notice from Health Canada, indicating planned expert scientific discussion that may inform…

psychiatry
View update →
EVENT
Advisory Committee: Scientific Advisory Committee Medical Devices Used in the Cardiovascular System
Health Canada • Published: Nov 16, 2026

Scientific Advisory Committee meeting materials on medical devices used in the cardiovascular system provide a structured forum for Health Canada to solicit…

cardiology
manufacturing
+4
View update →
EVENT
Advisory Committee: Science Advisory Committee on Pest Control Products
Health Canada • Published: Nov 16, 2026

Science Advisory Committee on Pest Control Products meetings are intended to inform Health Canada’s regulatory decision-making for pest control products by…

manufacturing
quality
+3
View update →
EVENT
Advisory Committee: Science Advisory Committee on Health Products Containing Cannabis
Health Canada • Published: Nov 16, 2026

Science Advisory Committee convenes to advise on health products containing cannabis, indicating ongoing Health Canada oversight and evidence-building to…

safety
clinical
+3
View update →
GUIDANCE FINAL
Updated: Guidance on nitrosamine impurities in medications
Health Canada • Published: Nov 5, 2026

Guidance on nitrosamine impurities in medications is updated, potentially tightening expectations for manufacturers to evaluate, control, and communicate…

infectious_disease
cardiology
+11
View update →
NOTICE
Notice to stakeholders on implementing ICH M13B: Bioequivalence for immediate release solid oral dosage forms: Additional strengths biowaiver
Health Canada • Published: Nov 4, 2026

Implements ICH M13B to support regulatory decisions on bioequivalence for immediate-release solid oral dosage forms, including use of additional-strength…

clinical
manufacturing
+3
View update →
NOTICE
Phased implementation of ICH M11: Clinical electronic Structured Harmonised Protocol (CeSHarP) – Notice to stakeholders
Health Canada • Published: Nov 4, 2026

Phased implementation of ICH M11 (CeSHarP) is expected to move Canadian sponsors toward standardized, electronic, structured harmonised clinical protocol…

clinical
safety
+3
View update →
NOTICE
Menopause Hormone Therapy – Estradiol Transdermal Patches in short supply in Canada: Notice
Health Canada • Published: Nov 4, 2026

Estradiol transdermal patches for menopause hormone therapy may be affected by a Canada-wide short supply situation, prompting regulator notice-level oversight…

dermatology
gastroenterology
+16
View update →

Get Health Canada alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.